Sale!

MAPT Gene Dementia Frontotemporal Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MAPT gene dementia frontotemporal genetic test is a specialized diagnostic tool aimed at identifying mutations in the MAPT gene, which have been linked to the development of frontotemporal dementia (FTD). FTD is a type of dementia that primarily affects the frontal and temporal lobes of the brain, leading to changes in personality, behavior, and language. The test is designed to help in the early detection and management of this condition by analyzing the patient’s DNA for specific genetic variations associated with the disease.

Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test offers a crucial resource for individuals with a family history of frontotemporal dementia or those exhibiting early symptoms of the disease. By identifying the genetic markers associated with FTD, healthcare providers can better understand the risk, tailor treatment plans, and offer genetic counseling to affected families.

The cost of the MAPT gene dementia frontotemporal genetic test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families can be immeasurable, potentially offering insights that enable more personalized and effective management of frontotemporal dementia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MAPT Gene Dementia Frontotemporal Genetic Test

Welcome to DNA Labs UAE, where we offer the MAPT Gene Dementia Frontotemporal Genetic Test. This test is designed to analyze the MAPT gene, which codes for the tau protein and plays a crucial role in the structure and function of neurons in the brain.

Test Details

Frontotemporal dementia (FTD) is a group of disorders that affect the frontal and temporal lobes of the brain. Mutations in the MAPT gene have been linked to FTD and other neurodegenerative disorders. Our NGS (next-generation sequencing) genetic testing method allows for a comprehensive analysis of an individual’s genetic makeup, including the identification of mutations in genes like MAPT that may increase the risk of developing FTD.

Test Components and Price

The MAPT Gene Dementia Frontotemporal Genetic Test is priced at 4400.0 AED. The test can be performed using blood or extracted DNA samples, or even just one drop of blood on an FTA card.

Sample Condition

We accept blood samples, extracted DNA samples, or one drop of blood on an FTA card for this test.

Report Delivery

Once the sample is received, the report will be delivered within 3 to 4 weeks.

Test Type

This test falls under the category of neurological disorders.

Referring Doctor

Our neurologist will oversee the MAPT Gene Dementia Frontotemporal Genetic Test.

Test Department

The test will be conducted in our Genetics department.

Pre Test Information

Prior to undergoing the MAPT Gene Dementia Frontotemporal Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by MAPT Gene Dementia Frontotemporal.

Important Considerations

It is crucial to note that genetic testing for dementia is not a definitive diagnostic tool. It should be used in conjunction with other clinical and diagnostic tests. Genetic testing can also have emotional and psychological implications, so it is important for individuals to carefully consider the potential risks and benefits before undergoing testing.

Test Name MAPT Gene Dementia frontotemporal Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MAPT Gene Dementia, frontotemporal NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MAPT Gene Dementia, frontotemporal
Test Details

The MAPT gene is a gene that codes for the tau protein, which plays a role in the structure and function of neurons in the brain. Mutations in this gene have been linked to several neurodegenerative disorders, including frontotemporal dementia (FTD), a group of disorders that affect the frontal and temporal lobes of the brain.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that can analyze multiple genes at once, allowing for a more comprehensive analysis of an individual’s genetic makeup. In the context of dementia, NGS genetic testing can help identify mutations in genes like MAPT that may increase an individual’s risk of developing FTD.

However, it’s important to note that genetic testing for dementia is not a definitive diagnostic tool and should be used in conjunction with other clinical and diagnostic tests. Additionally, genetic testing can have emotional and psychological implications, and individuals should consider the potential risks and benefits before undergoing testing.